MAPT and Cognitive impairment: lactis CKDB001 ameliorates scopolamine-induced cognitive impairment through coordinated modulation of the gut microbiota, microbial metabolites, lipid remodeling, intestinal barrier integrity, and both cholinergic and tau-associated signaling pathways.